C
Cibus, Inc. (CBUS)
NCM – Real Time Price. Currency in USD
1.43
+0.05 (3.62%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
1.43
+0.05 (3.62%)
At close: May 12, 2026, 4:00 PM EDT
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.
| Name | Position |
|---|---|
| Dr. Gregory F. Gocal Ph.D. | Co-Founder, Chief Scientific Officer & Executive VP |
| Dr. Noel Sauer Ph.D. | Senior Vice President of Research |
| Dr. Peter R. Beetham B.Sc., Ph.D. | Co-Founder, Interim CEO, President, COO & Director |
| Mr. Cornelis Broos M.Sc. | Chief Financial Officer |
| Mr. Jason Stokes Esq., J.D. | Chief Administrative Officer, General Counsel & Corporate Secretary |
| Mr. Rory Balfour Riggs M.B.A. | Co-Founder & Director |
| Ms. Rosa Cheuk Kim J.D. | Senior Vice President of Legal |
| Date | Type | Document |
|---|---|---|
| 2026-04-20 | DEFA14A | a2026noticeofinternetavail.htm |
| 2026-04-20 | DEF 14A | cbus-20260420.htm |
| 2026-04-10 | 8-K | cbus-20260407.htm |
| 2026-03-27 | 8-K | d73414d8k.htm |
| 2026-03-17 | 8-K | cbus-20260317.htm |
| 2026-01-30 | 8-K | d54299d8k.htm |
| 2026-01-06 | 8-K | cbus-20251231.htm |
| 2025-11-13 | 10-Q | cbus-20250930.htm |
| 2025-11-10 | 8-K | cbus-20251105.htm |
| 2025-09-23 | 8-K | d30632d8k.htm |